Acute myeloid leukemia

Abstract

Acute myeloid leukemia (AML) that is also known as non-lymphocytic anemia. Based on 2009–2013 cases and deaths analysis, the number of new cases of acute myeloid leukemia was 4.1 per 100,000 men and women per year and the number of deaths was 2.8 per 100,000 men and women per year. In 2016 AML constituted 19,950 from estimated new cases and 1.2 % of all new cancer cases with 10,430 of estimated deaths and 1.8 % of all cancer deaths. According to data review of 2006–2012, percent of patients surviving 5 years is 26.6 %. Based on 2011–2013 data, approximately 0.5 percent of men and women will be diagnosed with acute myeloid leukemia at some point during their lifetime, thus AML is the most common leukemia in adults, that proves the importance of its research.